Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population
Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population
NCT ID: NCT04322461 Phase: NA Status: COMPLETED Enrollment: 14 Completion: 2024-05-27
Conditions
Parkinson Disease, Alzheimer Disease
Interventions
Betaquik MCT supplement
Summary
A two months intervention in which two groups of cognitive disorders, Parkinson and Alzheimer's disease, will receive 50g/day of a commercial MCT supplement combined with supervised aerobic exercise 3 times/week. Cognition and ketones will be assess before and after the intervention, along with endocannabinoids plasma concentrations.
Primary Outcome
Cognition